Rheumatic Diseases Completed Phase 4 Trials for Abatacept (DB01281)

Also known as: Rheumatic Disease / Rheumatism, unspecified / Rheumatics / Rheumatism (disorder) / Rheumatism

IndicationStatusPhase
DBCOND0027857 (Rheumatic Diseases)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03492658Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)Treatment